that this
novel
therapy
is safe,
and most
participa
nts
experienc
ed
improveme
nts in
their
eczema.
NIH has
exclusive
ly
licensed
the
technolog
y to
Forte
Bioscienc
es to
advance
this
potential
new
therapy
through
further
clinical
developme
nt.

Gene
therapy:
NIAID is
developin
g and
applying
gene
correctio
n
technique
Ss to
treat a

NIH-001401
